Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
about
Aspergillus fumigatus and aspergillosisProphylactic Measures During Induction for Acute Myeloid Leukemia.Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.Lipid-based amphotericin B for the treatment of fungal infections.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerPanfungal PCR assay for detection of fungal infection in human blood specimens.Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients.Fungal infections in patients undergoing blood and marrow transplantation.A strategy for managing fungal infections in haematopoietic stem cell transplantation.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients.Antifungal prophylaxis during neutropenia and immunodeficiencyAntifungal prophylaxis following reduced-intensity stem cell transplantation.The prevalence of antifungal agents administration in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study.A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell levelAerosol amphotericin B for prevention of invasive pulmonary aspergillosis.Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsNovel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions.Antifungal prophylaxis in bone marrow transplant.Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.Amphotericin B disposition after aerosol inhalation in lung transplant recipients.Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation.
P2860
Q29617908-348E0E04-57D3-4F29-8955-024EEF2462FBQ30235496-7CA715AC-7536-4ACF-A287-82484EF3013DQ30596268-7ADE2777-67E8-4F61-9323-6BCCC2C84275Q31372000-DD6BC730-828F-4CB3-B3A0-01B6D799BAECQ33604227-9BEEAFFB-360D-45EB-8603-4280363218B3Q33650105-FCD13F6D-F459-42F7-B569-DBDBDF0A97A4Q33665050-AEDF8E9B-0731-48A0-8CB2-42CA68436A4EQ34073663-34F6A9C9-8FA3-45E5-A547-ABC0186653C2Q34294869-FB7FBF6D-46A4-4D8F-9049-984108707234Q34294925-F92F4895-F9D7-4042-8712-D68A59BA444FQ34532546-C7270764-40BA-47F8-9B6B-CED30BA37861Q34746953-B6B2C7E0-7B5C-452F-A9FB-47BD0B2F61D2Q35374928-08C42395-26EE-4332-AEBE-B6CD0FD853ADQ36658236-41E937C2-3102-44AE-B26A-9D358E544D5CQ37552737-36A00B1A-434C-4CB8-BA88-8E70BC02816EQ39377722-D540C824-96B3-456C-B158-9A3F28A9F4EDQ39559102-9D6FDAF5-E7E8-4253-93C9-4014E72BE64CQ39866214-B7CFFF58-A74B-45EE-935A-3149590534B3Q39866778-36D57FE3-418B-4A36-BA1F-483B4918CBA1Q40284723-4DEF3439-1219-45BD-B85F-26B2D4DB2E78Q40678339-06873899-A85C-4410-A203-19065C772AB5Q40938728-212D1E97-DB82-460C-B757-B0EB0F4DC299Q43560592-2DD80C7C-3839-4E44-9021-B3047A44EF67Q43869917-8614BAAE-FF6A-4FB4-9DD0-42C789D71747Q44062340-C1E4E1FC-CC07-4BA9-AD98-D8C13648F816Q44973658-6E1AEAE5-2778-465B-A9D2-47E88C96D7D7
P2860
Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@ast
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@en
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@nl
type
label
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@ast
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@en
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@nl
prefLabel
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@ast
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@en
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@nl
P2093
P1476
Low-dose amphotericin B prophy ...... ogeneic marrow transplantation
@en
P2093
P304
P356
10.1016/0002-9343(91)90184-Y
P407
P577
1991-11-01T00:00:00Z